BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1318951)

  • 1. Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study.
    Jeremic B; Grujicic D; Jevremovic S; Stanisavljevic B; Milojevic L; Djuric L; Mijatovic L
    J Clin Oncol; 1992 Jul; 10(7):1074-7. PubMed ID: 1318951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia.
    Brandes AA; Cavallo G; Reni M; Tosoni A; Nicolardi L; Scopece L; Franceschi E; Sotti G; Talacchi A; Turazzi S; Ermani M
    Cancer; 2005 Jul; 104(1):143-8. PubMed ID: 15912507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel.
    Ahmed M; Semreen AM; Giddey AD; Ramadan WS; El-Awady R; Soares NC; El-Huneidi W; Bustanji Y; Alqudah MAY; Alzoubi KH; Semreen MH
    Ann Med; 2023; 55(2):2305308. PubMed ID: 38253025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radio-chemotherapy feasibility for biopsy-only unresectable
    Harlay V; Appay R; Bequet C; Petrirena G; Campello C; Barrié M; Autran D; Graillon T; Boissonneau S; Dufour H; Figarella-Branger D; Padovani L; Barlier A; Nanni I; Tabouret E; Chinot O
    Neurooncol Pract; 2023 Dec; 10(6):536-543. PubMed ID: 38009116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characteristics of GWH04, a new primary human glioblastoma cell line.
    Cheng F; Wan X; Wang B; Li Y; Peng P; Xu S; Han C; Mao F; Guo D
    Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36169178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction.
    Roberts NB; Alqazzaz A; Hwang JR; Qi X; Keegan AD; Kim AJ; Winkles JA; Woodworth GF
    J Neurooncol; 2018 Dec; 140(3):497-507. PubMed ID: 30132163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Molecular Mechanisms of Plant-Derived Compounds Targeting Brain Cancer.
    Fan HC; Chi CS; Chang YK; Tung MC; Lin SZ; Harn HJ
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma.
    Roberts NB; Wadajkar AS; Winkles JA; Davila E; Kim AJ; Woodworth GF
    Oncoimmunology; 2016; 5(9):e1208876. PubMed ID: 27757301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating recurrent glioblastoma: an update.
    Kamiya-Matsuoka C; Gilbert MR
    CNS Oncol; 2015; 4(2):91-104. PubMed ID: 25768333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.
    Redjal N; Zhu Y; Shah K
    Stem Cells; 2015 Jan; 33(1):101-10. PubMed ID: 25186100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the art and perspectives in the treatment of glioblastoma.
    Grimm SA; Chamberlain MC
    CNS Oncol; 2012 Sep; 1(1):49-70. PubMed ID: 25054300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepia ink oligopeptide induces apoptosis in prostate cancer cell lines via caspase-3 activation and elevation of Bax/Bcl-2 ratio.
    Huang F; Yang Z; Yu D; Wang J; Li R; Ding G
    Mar Drugs; 2012 Oct; 10(10):2153-2165. PubMed ID: 23170075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin and bevacizumab for recurrent malignant glioma.
    Mrugala MM; Crew LK; Fink JR; Spence AM
    Oncol Lett; 2012 Nov; 4(5):1082-1086. PubMed ID: 23162656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts.
    Cheema TA; Kanai R; Kim GW; Wakimoto H; Passer B; Rabkin SD; Martuza RL
    Clin Cancer Res; 2011 Dec; 17(23):7383-93. PubMed ID: 21976549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomas.
    Harn HJ; Lin SZ; Lin PC; Liu CY; Liu PY; Chang LF; Yen SY; Hsieh DK; Liu FC; Tai DF; Chiou TW
    Neuro Oncol; 2011 Jun; 13(6):635-48. PubMed ID: 21565841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which therapy works better in choroid plexus carcinomas?
    Berrak SG; Liu DD; Wrede B; Wolff JE
    J Neurooncol; 2011 May; 103(1):155-62. PubMed ID: 20976614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors.
    Scopece L; Franceschi E; Cavallo G; Paioli A; Paioli G; Conforti R; Palmerini E; Berzioli C; Spagnolli F; Esposti RD; Crinò L
    J Neurooncol; 2006 Sep; 79(3):299-305. PubMed ID: 16645720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma.
    Franceschi E; Cavallo G; Scopece L; Paioli A; Pession A; Magrini E; Conforti R; Palmerini E; Bartolini S; Rimondini S; Esposti RD; Crinò L
    Br J Cancer; 2004 Sep; 91(6):1038-44. PubMed ID: 15305187
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.